Delivery Order SPE2DB20D3303-SPE2DB23FZ5X3
- Not listed
- This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,829.04, is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialized pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,849.62 firm fixed-price contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,719.85, is for the delivery of Sandostatin LAR Depot 20 mg kits, a specialty medication. The contract is a Firm Fixed Price, Delivery Order type with an ultimate completion date of February 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $23,516.34 Firm Fixed Price contract is for the delivery of the specialty medication Sandostatin LAR Depot 30 mg kits. The contract has an ultimate completion date of August 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,496.96 for the supply of Sandostatin LAR Depot 30 mg kits. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,914.52, is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication. The delivery order has a firm fixed-price pricing type and an ultimate completion date of February 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Sandostatin LAR Depot 30 mg kits. The contract has a firm fixed price of $18,206.36 and an ultimate completion date of August 9, 2024. The contract is a delivery order, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,955.42, is for the supply of Sandostatin LAR Depot 10 mg kits, a specialty medication. The contract has an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FZ5X3Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sandostatin LAR Depot 30 mg drug kits. The $7,522.17 fixed-price contract has a completion date of May 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This specific delivery order is not designated under any set-aside program, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical commodities to various federal agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/15/23 |